Literature DB >> 26796957

Sensitivity and specificity of on-farm scoring systems and nasal culture to detect bovine respiratory disease complex in preweaned dairy calves.

William J Love1, Terry W Lehenbauer1, Alison L Van Eenennaam1, Christiana M Drake1, Philip H Kass1, Thomas B Farver1, Sharif S Aly2.   

Abstract

The California (CA) and Wisconsin (WI) clinical scoring systems have been proposed for bovine respiratory disease complex (BRDC) detection in preweaned dairy calves. The screening sensitivity (SSe), for estimating BRDC prevalence in a cohort of calves, diagnostic sensitivity (DSe), for confirming BRDC in ill calves, and specificity (Sp) were estimated for each of the scoring systems, as well as for nasal swab cultures for aerobic bacteria and mycoplasma species. Thoracic ultrasound and auscultation were used as the reference standard tests interpreted in parallel. A total of 536 calves (221 with BRDC and 315 healthy) were sampled from 5 premises in California. The SSe of 46.8%, DSe of 72.6%, and Sp of 87.4% was determined for the CA system. The SSe of 46.0%, DSe of 71.1%, and Sp of 91.2% was determined for the WI system. For aerobic culture, the SSe was 43.4%, DSe was 52.6%, and Sp was 71.3%; for Mycoplasma spp. culture, the SSe was 57.5%, DSe was 68.9%, and Sp was 59.7%. The screening and diagnostic sensitivities of the scoring systems were not significantly different but the Sp of the WI system was greater by 3.8%. Scoring systems can serve as rapid on-farm tools to determine the burden of BRDC in preweaned dairy calves. However, users may expect the SSe to be less than the DSe when confirming BRDC in an ill calf.
© 2016 The Author(s).

Entities:  

Keywords:  Bovine respiratory disease; pneumonia; preweaned dairy calves; screening tests

Mesh:

Year:  2016        PMID: 26796957     DOI: 10.1177/1040638715626204

Source DB:  PubMed          Journal:  J Vet Diagn Invest        ISSN: 1040-6387            Impact factor:   1.279


  7 in total

1.  Association of plasma haptoglobin concentration and other biomarkers with bovine respiratory disease status in pre-weaned dairy calves.

Authors:  Sonia J Moisá; Sharif S Aly; Terry W Lehenbauer; William J Love; Paul V Rossitto; Alison L Van Eenennaam; Sophia C Trombetta; Eduarda M Bortoluzzi; Lindsey E Hulbert
Journal:  J Vet Diagn Invest       Date:  2018-10-17       Impact factor: 1.279

2.  Inter-rater agreement and reliability of thoracic ultrasonographic findings in feedlot calves, with or without naturally occurring bronchopneumonia.

Authors:  S Buczinski; C Buathier; A M Bélanger; H Michaux; N Tison; E Timsit
Journal:  J Vet Intern Med       Date:  2018-08-22       Impact factor: 3.333

3.  Management factors associated with bovine respiratory disease in preweaned calves on California dairies: The BRD 100 study.

Authors:  G U Maier; W J Love; B M Karle; S A Dubrovsky; D R Williams; J D Champagne; R J Anderson; J D Rowe; T W Lehenbauer; A L Van Eenennaam; S S Aly
Journal:  J Dairy Sci       Date:  2019-06-13       Impact factor: 4.034

Review 4.  Bovine respiratory microbiota of feedlot cattle and its association with disease.

Authors:  Jianmin Chai; Sarah F Capik; Beth Kegley; John T Richeson; Jeremy G Powell; Jiangchao Zhao
Journal:  Vet Res       Date:  2022-01-12       Impact factor: 3.683

5.  Feeding behavior and activity levels are associated with recovery status in dairy calves treated with antimicrobials for Bovine Respiratory Disease.

Authors:  M C Cantor; David L Renaud; Heather W Neave; Joao H C Costa
Journal:  Sci Rep       Date:  2022-03-22       Impact factor: 4.379

6.  Validation of a clinical scoring system for bovine respiratory disease complex diagnosis in preweaned dairy calves using a Bayesian framework.

Authors:  S Buczinski; G Fecteau; J Dubuc; D Francoz
Journal:  Prev Vet Med       Date:  2018-05-04       Impact factor: 2.670

7.  The Effect of Contract-Rearing on the Health Status of Replacement Dairy Heifers.

Authors:  Marie-Claire McCarthy; Luke O'Grady; Conor G McAloon; John F Mee
Journal:  Animals (Basel)       Date:  2021-12-03       Impact factor: 2.752

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.